Fundraising FoxPrenostics
2 known investors
Find your way into Prenostics
Sign up to see every warm intro you have to Prenostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Prenostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment. Its initial clinical targets are women at elevated risk of ovarian cancer and people with indeterminate lung nodules.
Founders & leadership
SB
Sarah BlagdenFounder & CSO
Investors · 2
Frequently asked questions
- What does Prenostics do?
- Prenostics develops a blood test to detect the earliest stages of cancer (stages 0-2), earlier than current methods, aiming to enable curative treatment. Its initial clinical targets are women at elevated risk of ovarian cancer and people with indeterminate lung nodules.
- Who founded Prenostics?
- Prenostics was founded by Sarah Blagden.
- Who are Prenostics's investors?
- Prenostics's investors include Pace Ventures, Sie Ventures.